Sunho Biologics, Inc. Stock

Equities

2898

KYG8572S1021

Biotechnology & Medical Research

Delayed Hong Kong S.E. 09:30:50 2024-07-04 pm EDT 5-day change 1st Jan Change
7.14 HKD +0.14% Intraday chart for Sunho Biologics, Inc. +1.28% 0.00%

Financials

Sales 2022 1.85M 255K 1.99M Sales 2023 17.53M 2.41M 18.84M Capitalization 981M 135M 1.05B
Net income 2022 -52M -7.15M -55.87M Net income 2023 -133M -18.3M -143M EV / Sales 2022 * -
Net cash position 2022 * - 0 0 Net cash position 2023 * - 0 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees -
Yield 2022 *
-
Yield 2023 *
-
Free-Float 30.47%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.14%
1 week+1.28%
Current month+1.28%
1 month-3.12%
More quotes
1 week
6.23
Extreme 6.23
7.67
1 month
5.00
Extreme 5
7.70
Current year
5.00
Extreme 5
15.42
1 year
5.00
Extreme 5
15.42
3 years
5.00
Extreme 5
15.42
5 years
5.00
Extreme 5
15.42
10 years
5.00
Extreme 5
15.42
More quotes
Date Price Change Volume
24-07-04 7.14 +0.14% 2 800
24-07-04 7.13 +1.86% 7,600
24-07-03 7 +4.63% 37,800
24-07-02 6.69 -5.11% 27,200
24-06-28 7.05 +5.22% 171,800

Delayed Quote Hong Kong S.E., July 04, 2024 at 09:30 pm EDT

More quotes
Sunho Biologics Inc is a company mainly engaged in the research, development and production of biotechnology. The Company is primarily engaged in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The Company has three core products, namely IAH0968, IAP0971 and IAE0972. IAH0968 is an antibody-dependent cell-mediated cytotoxicity-enhancing monoclonal antibody. IAP0971 and IAE0972 are both antibody cytokines.
More about the company